
PhD-trained neuroscientist and Science and Technology Lead on ARIA’s £69m Precision Neurotechnologies programme. I use technical judgement to convert biological, hardware, software and clinical uncertainty into clear portfolio decisions. I am driven by shaping translational pathways, strengthening cross-sector partnerships and securing investment to advance promising projects. I actively apply evidence-led judgement to programme reviews, milestone setting and risk management.